Vanguard Group Inc Vor Biopharma Inc. Put Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VOR
# of Institutions
43Shares Held
55.7MCall Options Held
4.15MPut Options Held
364K-
Ra Capital Management, L.P. Boston, MA39.6MShares$1.55 Billion1.4% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$248 Million6.91% of portfolio
-
Ubs Group Ag1.53MShares$59.7 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$41.9 Million0.59% of portfolio
-
Jane Street Group, LLC New York, NY526KShares$20.5 Million0.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $1.48B
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...